查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942351

透析市场规模、份额、趋势及预测（按类型、产品类型、服务、最终用户和地区划分），2026-2034年

Dialysis Market Size, Share, Trends and Forecast by Type, Product and Services, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

2025年全球透析市场规模为1,258亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到1,812亿美元，2026年至2034年的复合年增长率（CAGR）为4.14%。截至2025年，北美市场占据主导地位，市占率达41.0%。推动市场成长的主要因素包括：慢性肾臟病和末期肾功能衰竭盛行率不断上升、糖尿病和高血压病例增加、透析设备技术进步、医疗费用支出不断增长、家庭透析解决方案的广泛应用、有利的政府政策、报销机制以及全球人口老化。

全球市场的主要驱动力是慢性肾臟病(CKD) 和末期肾功能衰竭(ESRD) 盛行率的不断上升。根据行业报告显示，65 岁及以上人口的比例预计将从 2024 年的 10% 增长到 2050 年的 16% 以上。如果 1990 年至 2016 年的趋势持续下去，到 2050 年，许多地区 3 至 5 级 CKD 的盛行率可能超过 10%，这主要是由于糖尿病和高血压的增加，而糖尿病和高血压是慢性肾臟病疾病的主要危险因子。老年人口的成长以及已开发国家和开发中国家医疗费用支出的增加正在推动市场成长。此外，透析设备和治疗技术的不断进步以及人们对肾臟健康的意识提升也是推动市场成长的因素。同时，政府的积极措施、报销政策以及家庭透析解决方案的广泛应用也提升了市场的吸引力。

美国作为重要的区域市场脱颖而出，其主要驱动力是慢性肾臟病(CKD) 和末期肾功能衰竭(ESRD) 患病率的上升，而这主要是由于糖尿病和高血压病例的增加。反过来，这又因老龄化族群肾病风险的增加而推动了市场需求。此外，透析设备的技术创新，例如改进的过滤方法、提高材料的生物相容性、更精确的监测系统、用于个人化治疗的自动化以及与远端医疗的整合，都使患者就医更加便捷，并推动了市场发展。例如，费森尤斯于2024年12月6日宣布计划于2025年在美国实现其广泛应用的血液透析滤过 (HDF) 技术的商业化，并强调该技术有望透过改善对流清除率和降低住院率来改善患者预后。在2024年肾臟週上，费森尤斯重点展示了其5008X透析机。该设备无需对供水系统进行大规模维修即可实现门诊血液透析滤过（HDF），研究表明，与标准血液透析相比，HDF在降低死亡率、改善贫血和提高生活品质方面均有显着优势。此外，联邦医疗保险（Medicare）和联邦医疗补助（Medicaid）的优惠报销政策也大大促进了病患获得治疗的机会。同时，大型透析服务供应商的存在也推动了美国透析市场的扩张。

透析市场趋势：

生活方式的改变日益频繁，导致肾臟併发症。

生活方式的改变正在推动市场发展。根据美国国立卫生研究院 (NIH) 统计，慢性肾臟病(CKD) 影响着超过七分之一的美国成年人，估计影响着 3,550 万美国人，凸显了其日益严重的公共卫生问题。不健康的饮食习惯，例如过度食用加工食品、高盐饮食和水分摄取不足，会导致高血压和糖尿病等慢性疾病，而这些疾病正是肾臟疾病的主要诱因。生活方式因素与肾臟併发症之间的关联性正在加剧慢性肾臟病的盛行率。肾臟相关疾病的增加推动了透析治疗的需求，因为患者需要肾臟替代疗法来维持生活品质。患者数量的不断增长使得扩大透析服务势在必行，进一步推动了市场发展。此外，医疗保健机构、医疗设备製造商和研究人员的持续创新正在促进解决方案和策略的开发，以满足不断增长的需求并提供有效的透析干预措施，从而进一步促进市场发展。

私人透析诊所和中心的扩张

私人透析诊所和中心的兴起，凭藉其诸多关键优势，正在推动市场扩张。根据美国国家医学图书馆统计，印度约有950名肾臟科医师和700多家透析中心（配备4,000多台透析机），其中大部分为私人机构，且主要集中在大都会圈。透析需求的不断增长正推动着私人透析机构在全国范围内的扩张。私人诊所通常提供针对每位患者独特需求的专业化、个人化照护。这种客製化护理能够提高患者满意度和治疗效果，从而吸引更多患者，并增强市场需求。此外，私人透析中心提供更灵活的预约安排，充分考虑患者的便利性和日常生活习惯。这种便利性吸引了那些希望在忙碌生活中寻求合适治疗方案的患者。同时，私人诊所的建立也促进了市场内的良性竞争。这种竞争鼓励治疗方法的创新、技术的应用以及病患服务的改进，最终提升整个产业的医疗品质。此外，私立透析中心通常配备最新的透析设备和技术，以及技术精湛的医护人员，确保高效优质的治疗。这种高标准的护理有助于建立患者和转诊医生之间的信任，从而促进更多患者转诊和市场成长。私立透析中心为寻求透析服务的患者提供了另一种选择，有助于减轻公共医疗系统的负担。这在公共资源有限的地区尤其重要，因为私人透析中心可以减轻医疗基础设施的压力。

对改良型腹膜透析技术的需求日益增长

持续性携带式腹膜透析 (CAPD) 和自动化腹膜透析 (APD) 的需求不断增长，推动了市场发展。根据通报，在美国，夜间自动化腹膜透析 (APD) 的使用率正在上升，占新腹膜透析 (PD) 患者的 86%，这标誌着治疗方法正显着朝向更先进的方向发展。这些先进的腹膜透析技术因其诸多优势而日益普及。与传统的中心血液透析相比，CAPD 和 APD 为患者提供了更灵活、更方便的治疗选择。 CAPD 让患者在白天手动更换透析液，即使在接受治疗的同时，也能更自由地进行日常活动。 APD 更进一步，让机器能够在夜间自动完成透析液更换，让患者在睡眠中也能接受治疗。 CAPD 和 APD 持续稳定的毒素清除能力，能够稳定血液化学成分并改善整体健康状况，从而推动了市场需求的成长。这些技术还能尽量减少患者频繁前往透析中心的次数，进而减少对患者日常生活的干扰。此外，CAPD 和 APD 非常适合居家照护，符合个人化医疗和远端监测日益增长的趋势。患者可以接受训练在家中进行这些操作，从而增强他们对自身治疗的掌控感和自主性。随着患者和医疗服务提供者对 CAPD 和 APD 益处的认识不断加深，预计对这些技术的需求将会增加。这反过来又推动了腹膜透析技术的进一步研究和创新，以及针对选择这些方法的患者提供的培训项目和支援服务的扩展，从而促进了市场成长。

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章 引言

第五章 全球透析市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 按类型分類的市场区隔

  • 血液透析
    • 主要部分
      • 传统血液透析
      • 短期门诊血液透析
      • 夜间血液透析
  • 腹膜透析
    • 主要部分
      • 持续性携带式腹膜透析（CAPD）
      • 自动腹膜透析（APD）

第七章 按产品和服务分類的市场细分

  • 服务
  • 装置
    • 主要部分
      • 透析机
      • 水处理系统
      • 其他的
  • 消耗品
    • 主要部分
      • 透析器
      • 导管
      • 其他的
  • 透析药物

第八章 按最终用户分類的市场细分

  • 中心透析
  • 居家透析

第九章 按地区分類的市场细分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章 SWOT 分析

第十一章 价值链分析

第十二章 波特五力分析

第十三章：定价分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Asahi Kasei Medical Co., Ltd.
    • B. Braun Medical Inc.
    • Becton, Dickinson and Company
    • DaVita Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • JMS Co. Ltd.
    • Nikkiso Co. Ltd.
    • NIPRO Corporation
    • Satellite Healthcare Inc.
    • Teleflex Incorporated
    • Toray Medical Co., Ltd.
    • Vantive Health LLC（Baxter International Inc）
Product Code: SR112026A5940

The global dialysis market size was valued at USD 125.8 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 181.2 Billion by 2034, exhibiting a CAGR of 4.14% during 2026-2034. North America currently dominates the market in 2025, accounting to 41.0% of the market share. The major drivers of the market include the increasing prevalence of chronic kidney disease and end-stage renal disease, rising diabetes and hypertension cases, technological advancements in dialysis equipment, growing healthcare spending, expanding home dialysis solutions, favorable government policies, reimbursement initiatives, and an aging global population.

The global market is majorly driven by the increasing prevalence of chronic kidney disease and end-stage renal disease. As per industry reports, the proportion of individuals aged 65 years or older is projected to increase from 10% in 2024 to over 16% by 2050. If trends from 1990 to 2016 continue, the prevalence of CKD in categories G3-G5 will likely exceed 10% in many regions by 2050, mainly due to rising rates of diabetes and hypertension, which are key risk factors for kidney disorders. This increase in geriatric population, along with increased healthcare spend in developed and developing economies is providing a boost to the market growth. Additionally, ongoing technological advancements in dialysis equipment and procedures and awareness about renal health is propelling the market. Apart from this, favorable government initiatives, reimbursement policies, and availability of home dialysis solutions are stimulating the market appeal.

The United States stands out as a key regional market, and is primarily driven by the growing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), mainly due to increasing cases of diabetes and hypertension. In line with this, growing demographics with a higher inclination towards age-related kidney issues is increasing the demand further. Furthermore, ongoing technological advancements in dialysis machines, such as improved filtration methods, better biocompatibility of materials, more precise monitoring systems, and automation for personalized treatment, and telehealth integration is making the process more convenient for patients, thereby supporting the market. For instance, on December 6, 2024, Fresenius announced plans for a broad U.S. commercial launch of hemodiafiltration (HDF) technology in 2025, emphasizing its potential to improve patient outcomes through increased convective clearance and reduced hospitalizations. During Kidney Week 2024, Fresenius highlighted its 5008X dialysis machine, which enables outpatient HDF without significant water system retrofitting, and showcased studies demonstrating HDF's benefits in mortality, anemia, and quality of life compared to standard hemodialysis. Besides this, favorable reimbursement policies by Medicare and Medicaid significantly support accessibility to treatment. Moreover, the presence of major dialysis service providers, is contributing to the expansion of the dialysis market in the U.S.

Dialysis Market Trends:

Increasing lifestyle changes lead to kidney complications

The escalating trend of lifestyle changes is stimulating the market.. According to National Institutes of Health, chronic kidney disease (CKD) affects over 1 in 7 U.S. adults, impacting an estimated 35.5 million Americans, highlighting a growing public health concern. Unhealthy diets rich in processed foods, high salt content, and inadequate hydration can lead to chronic conditions such as hypertension and diabetes, which are major causes of kidney diseases. The correlation between lifestyle factors and kidney complications has prompted an upswing in the prevalence of chronic kidney diseases. This rise in kidney-related issues subsequently increased the demand for dialysis treatments, as affected individuals require renal replacement therapy to maintain their quality of life. The expanding patient pool necessitates the expansion of dialysis services, further propelling the market. Apart from this, ongoing innovations by healthcare providers, medical device manufacturers, and researchers to develop solutions and strategies to address this growing demand and offer effective dialysis interventions, is fostering the market further.

Expansion of private dialysis clinics and centers

The rise in the number of private dialysis clinics and centers that offer several key advantages contribute to the impact on market expansion. According to National Library of Medicine, India has nearly 950 nephrologists and over 700 dialysis centers with 4,000 machines, predominantly in the private sector, largely concentrated in metros. The growing demand for dialysis is driving the expansion of private facilities across the country. Private clinics often provide specialized and personalized care tailored to the unique needs of individual patients. This level of customization improves patient satisfaction and outcomes, attracting a larger clientele and strengthening the market demand. Furthermore, private dialysis centers tend to offer more flexible scheduling options, accommodating patients' preferences and routines. This convenience factor attracts individuals seeking treatments that align with their busy lifestyles. Moreover, the establishment of private clinics fosters healthy competition within the market. This competition encourages innovation in treatment methodologies, technology adoption, and patient services, ultimately leading to improved quality of care across the industry. Additionally, private facilities are often well-equipped with the latest dialysis machines, technologies, and skilled medical personnel, ensuring efficient and effective treatments. This high standard of care helps build trust among patients and referring physicians, further driving patient referrals and market growth. Private dialysis clinics contribute to reducing the burden on public healthcare systems by providing alternative options for patients seeking dialysis services. This aspect is particularly crucial in regions with limited public resources, as private centers can alleviate strain on the healthcare infrastructure.

Rising demand for Improved Peritoneal Dialysis Techniques

The escalating demand for continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) is fueling the market growth. According to reports, nocturnal automated peritoneal dialysis (APD) usage rising in the United States, now comprises 86% of patients on incident peritoneal dialysis (PD), reflecting a significant shift towards more advanced treatment options. These advanced peritoneal dialysis techniques offer numerous advantages that contribute to their increasing popularity. CAPD and APD provide patients with more flexible and convenient treatment options than traditional in-center hemodialysis. CAPD allows patients to perform manual exchanges of dialysate fluid throughout the day, offering greater freedom and the ability to continue daily activities while undergoing treatment. APD takes convenience a step further by utilizing a machine to automate dialysate exchanges at night, allowing patients to receive treatment while they sleep. The demand for CAPD and APD is driven by their ability to provide steady and continuous toxin removal, leading to more stable blood chemistry and improved overall health. These techniques also minimize the need for frequent visits to a dialysis center, reducing the disruption to patients' daily lives. Furthermore, CAPD and APD are well-suited for home-based care, aligning with the growing trend towards personalized healthcare and remote monitoring. Patients can receive training to perform these procedures at home, giving them a sense of empowerment and control over their treatment. As patients and healthcare providers increasingly recognize the benefits of CAPD and APD, the demand for these techniques is expected to rise. This, in turn, is fueling market growth by encouraging further research and innovation in peritoneal dialysis technology, as well as the expansion of training programs and support services for patients opting for these methods.

Dialysis Industry Segmentation:

Analysis by Type:

  • Hemodialysis
    • Conventional Hemodialysis
    • Short Daily Hemodialysis
    • Nocturnal Hemodialysis
  • Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • Automated Peritoneal Dialysis (APD)

Hemodialysis stands as the largest component in 2025, accounting to 97.6% of the market share. Hemodialysis, a prominent renal replacement therapy, exerts substantial influence due to its widespread adoption and several associated factors. Its efficacy in rapidly removing toxins, excess fluids, and waste products from the bloodstream addresses crucial medical needs in patients with kidney dysfunction. As a result, its demand is driven by the growing prevalence of chronic kidney diseases, kidney failures, and related conditions. The continuous advancement of hemodialysis technology improved treatment outcomes and patient experiences. Innovations such as high-efficiency dialyzers, vascular access techniques, and online monitoring systems have made hemodialysis more effective, comfortable, and accessible. Moreover, establishing specialized hemodialysis centers and integrating telehealth solutions widened the reach of this treatment, making it accessible to more patients, including those in remote areas. These factors combined contribute to the segment's pivotal role in driving overall market growth as the demand for efficient renal replacement therapies rises.

Analysis by Product and Services:

  • Services
  • Equipment
    • Dialysis Machines
    • Water Treatment Systems
    • Others
  • Consumables
    • Dialyzers
    • Catheters
    • Others
  • Dialysis Drugs

Services lead the market in 2025, accounting to 79.0% of the market share. This segment encompasses a range of essential offerings that directly impact patient care, treatment accessibility, and overall industry expansion. Medical service providers, including healthcare professionals and specialized dialysis clinics, contribute significantly to the growth of this segment. These services encompass various aspects of patient care, from initial diagnosis and treatment planning to ongoing monitoring and support. The availability of high-quality medical services is crucial in attracting patients to seek timely interventions for kidney-related issues, which is another factor contributing to the growth of this segment.

Analysis by End User:

  • In-center Dialysis
  • Home Dialysis

In- center dialysis leads the market in 2025. In-center dialysis refers to treatments conducted within specialized dialysis centers or clinics under the supervision of trained medical professionals. This setting offers various advantages, including access to advanced medical equipment, close monitoring by healthcare staff, and the opportunity for patients to interact with peers facing similar health challenges. The convenience and comprehensive care provided by in-center dialysis centers attract patients who require regular and closely supervised treatments. This includes individuals with advanced kidney diseases, complex medical histories, or those who benefit from personalized care plans. Moreover, in-center dialysis centers often house cutting-edge technology and skilled healthcare teams, ensuring high-quality treatment delivery. Moreover, in-center dialysis provides patients with structured environment, professional support, and regular check-ins. This segment caters to a substantial portion of the patient population, contributing significantly to the demand for dialysis services.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 41.0%. With its well-established healthcare infrastructure, North America is at the forefront of adopting and implementing innovative dialysis technologies and treatment methodologies. This region's focus on research and development (R&D) fosters continuous advancements in dialysis machines, equipment, and treatment protocols, enhancing the overall quality of patient care. The increasing prevalence of chronic kidney diseases, often associated with lifestyle factors such as obesity and diabetes, drives the demand for dialysis services in North America. A significant aging population also contributes to the rising need for renal replacement therapies. Supportive government initiatives, reimbursement policies, and awareness campaigns further promote early diagnosis and intervention for kidney-related issues, augmenting the utilization of dialysis treatments. Additionally, the concentration of leading dialysis companies and medical research institutions in North America fuels the development and dissemination of state-of-the-art dialysis solutions.

Key Regional Takeaways:

United States Dialysis Market Analysis

In 2025, the United States accounted for 87.80% of the North America dialysis market. The increasing focus on the betterment of healthcare systems led to considerable financial inputs aimed at improving access to life-saving treatments. Reports indicate that in 2023, the U.S. spent USD 4.9 Trillion on healthcare, where 60% of the total expenditure was comprised of hospital care, physician and clinical services, and retail prescription drugs. This trend has had significant beneficial effects on the services regarding dialysis. Also, efforts made to increase advanced treatment centers, modernization of machinery, and furthering specialty training for medical professionals have increased in uptake. Policies with an ultimate goal of improved patient-care outcomes have been fast movers in creating innovations specifically intended to suit needs in providing regular renal support to persons. The availability of funding has facilitated the establishment of numerous treatment centers, reduced patient travel time and improving accessibility. Furthermore, initiatives to promote awareness about chronic kidney conditions and their management have encouraged earlier intervention and greater reliance on these life-sustaining therapies. The integration of advanced technology to support better patient monitoring and efficient workflows further propelled adoption rates, making it a critical component of healthcare improvement strategies.

Asia Pacific Dialysis Market Analysis

With the increasing rise of kidney-related illnesses, the trend of adopting dialysis at most health care centers has also emerged. Thereby, notably, the instances of kidney failure, at nearly 210,000 new cases every year, call for an immediate requirement for dialysis adoption-an approach that saves lives by being a lifesaving means for the effective management of chronic conditions. An accelerating awareness of advanced treatment facilities and better access to health care encouraged patients to take dialysis as a necessary solution for chronic illnesses. Moreover, the escalating lifestyle diseases such as hypertension and diabetes have significantly increased the risk of diseases for kidneys, which in turn is creating further demand for dialysis. Furthermore, ongoing technological advancements in equipment and techniques of dialysis are also contributing to an increased acceptance rate as a result of improved comfort along with effectiveness. Urbanization and changes in the existing healthcare infrastructure have made dialysis accessible to larger populations even in areas where awareness remained limited. Additionally, government favorable initiatives and educational campaigns are also assisting in early diagnosis and subsequent timely intervention, thereby highlighting the role of dialysis in prolonging life expectancy and improving patient outcomes. The number of individuals requiring dialysis continues to increase steadily, due to an aging population with a growing burden of chronic diseases.

Europe Dialysis Market Analysis

The increasing number of home-based treatments has improved the care delivery system as it offers more convenience and independence to the patients. For instance, home dialysis in the UK is in rapid increase with more than 25,000 currently undergoing treatment. Hemodialysis cases increased by 10%. Flexibility in their treatment schedules enables people to integrate therapy into their day-to-day activities, improve adherence, and satisfaction. This model reduces dependence on in-clinic visits. Thereby, it reduces the pressure on healthcare infrastructure and will enable providers to focus on resource-intensive cases. Portable equipment, combined with tailored support services has made home-based options accessible and effective. Remote monitoring and virtual consultations have ensured consistent oversight by healthcare professionals, addressing patient concerns promptly. Training programs for patients and caregivers further strengthen the feasibility of administering therapies outside traditional settings. Such developments have reinforced adoption, particularly among those seeking greater control over their healthcare journey. These trends highlight the growing importance of personalized, patient-centric solutions in addressing chronic kidney conditions.

Latin America Dialysis Market Analysis

Expanding private sector involvement increased the adoption of advanced medical treatments by fostering innovation and competition. According to International Trade Administration, Brazil, the largest healthcare market in Latin America, spends 9.47% of its GDP (USD161 Billion) on healthcare, with 62% of its 7,191 hospitals being private. High-quality dialysis services are becoming increasingly accessible due to investments in modern facilities and advanced technologies. Private healthcare providers prioritize efficient service delivery and patient satisfaction, which resulted in streamlined processes and tailored treatment plans. Improved infrastructure supports specialized centers catering to renal conditions, reducing waiting times and improving outcomes. Public-private collaborations have also contributed to improving accessibility for a broader demographic, addressing the rising demand for reliable and effective therapies. This dynamic growth has positioned renal treatments as a key area for ongoing improvement and patient-centered care.

Middle East and Africa Dialysis Market Analysis

Expanding infrastructure has been pivotal in improving access to essential medical services. According to Dubai Healthcare City Authority report, by 2022, Dubai had 4,482 private medical facilities, including 56 hospitals, and 55,208 licensed professionals. With projected growth of 10-15% in medical professionals and 3-6% in facilities, the expanding healthcare sector will improve dialysis care accessibility. Newly developed treatment centers and improved diagnostic capabilities have played a crucial role in addressing the growing prevalence of renal conditions. These developments have ensured that therapies are more widely available, even in remote areas. Investment in workforce development has improved the expertise of medical professionals, ensuring high-quality care delivery. Community outreach programs have raised awareness about chronic kidney conditions and the importance of early intervention, encouraging increased reliance on advanced therapies. The incorporation of innovative solutions to improve treatment efficiency has further propelled the adoption of dialysis as a critical healthcare service.

Competitive Landscape:

The dialysis market is very competitive, with numerous healthcare providers, equipment manufacturers, and service operators. The market is technologically driven, with companies trying to innovate in developing dialysis machines, home dialysis solutions, and integrated care models. High demand for personalized treatment and cost-effective therapies resulted in massive investments in research and development (R&D). Expanding infrastructures of healthcare, government support, and effective reimbursement policies are also accelerating market competition. Providers' differentiation is also done through service quality, patient outcome, and strategic partnerships for expanding market share and to meet the increasing flow of patients.

The report provides a comprehensive analysis of the competitive landscape in the dialysis market with detailed profiles of all major companies, including:

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Medical Inc.
  • Becton, Dickinson and Company
  • DaVita Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • JMS Co. Ltd.
  • Nikkiso Co. Ltd.
  • NIPRO Corporation
  • Satellite Healthcare Inc.
  • Teleflex Incorporated
  • Toray Medical Co., Ltd.
  • Vantive Health LLC (Baxter International Inc)

Key Questions Answered in This Report

  • 1.How big is the dialysis market?
  • 2.What is the future outlook of the dialysis market?
  • 3.What are the key factors driving the dialysis market?
  • 4.Which region accounts for the largest dialysis market share?
  • 5.Which are the leading companies in the global dialysis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Dialysis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Hemodialysis
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Conventional Hemodialysis
      • 6.1.2.2 Short Daily Hemodialysis
      • 6.1.2.3 Nocturnal Hemodialysis
    • 6.1.3 Market Forecast
  • 6.2 Peritoneal Dialysis
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
      • 6.2.2.2 Automated Peritoneal Dialysis (APD)
    • 6.2.3 Market Forecast

7 Market Breakup by Product and Services

  • 7.1 Services
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Equipment
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Dialysis Machines
      • 7.2.2.2 Water Treatment Systems
      • 7.2.2.3 Others
    • 7.2.3 Market Forecast
  • 7.3 Consumables
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Dialyzers
      • 7.3.2.2 Catheters
      • 7.3.2.3 Others
    • 7.3.3 Market Forecast
  • 7.4 Dialysis Drugs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 In-center Dialysis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Dialysis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Asahi Kasei Medical Co., Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Medical Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Becton, Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 DaVita Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Fresenius Medical Care AG & Co. KGaA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 JMS Co. Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Nikkiso Co. Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 NIPRO Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Satellite Healthcare Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Teleflex Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Toray Medical Co., Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Vantive Health LLC (Baxter International Inc)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Dialysis Market: Major Drivers and Challenges
  • Figure 2: Global: Dialysis Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Dialysis Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Dialysis Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Dialysis Market: Breakup by Product and Services (in %), 2025
  • Figure 6: Global: Dialysis Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Dialysis Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Dialysis (Hemodialysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Dialysis (Hemodialysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Dialysis (Peritoneal Dialysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Dialysis (Peritoneal Dialysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Dialysis (Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Dialysis (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Dialysis (Equipment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Dialysis (Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Dialysis (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Dialysis (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Dialysis (Dialysis Drugs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Dialysis (Dialysis Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Dialysis (In-center Dialysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Dialysis (In-center Dialysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Dialysis (Home Dialysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Dialysis (Home Dialysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: United States: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: United States: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Canada: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Canada: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Asia-Pacific: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Asia-Pacific: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: China: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: China: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Japan: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Japan: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: India: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: India: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: South Korea: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: South Korea: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Australia: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Australia: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Indonesia: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Indonesia: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Others: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Others: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Germany: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Germany: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: France: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: France: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United Kingdom: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United Kingdom: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Italy: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Italy: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Spain: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Spain: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Russia: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Russia: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Latin America: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Latin America: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Brazil: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Brazil: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Mexico: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Mexico: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Middle East and Africa: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Middle East and Africa: Dialysis Market: Breakup by Country (in %), 2025
  • Figure 72: Middle East and Africa: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Global: Dialysis Industry: SWOT Analysis
  • Figure 74: Global: Dialysis Industry: Value Chain Analysis
  • Figure 75: Global: Dialysis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Dialysis Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Dialysis Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Dialysis Market Forecast: Breakup by Product and Services (in Million USD), 2026-2034
  • Table 4: Global: Dialysis Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Dialysis Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Dialysis Market: Competitive Structure
  • Table 7: Global: Dialysis Market: Key Players